Intelligence Profile
Research Papers
Research Papers and Clinical Trials
Recent research on humanin, a mitochondrial-derived peptide, has expanded across multiple therapeutic areas, though much of the current evidence comes from preclinical studies.
Diabetes and Metabolic Research
Two 2026 studies examined humanin's effects in diabetes models. One study investigated humanin's protective effects against testicular damage in streptozotocin-induced diabetic mice, while another found that humanin restored metabolic hormone balance (including leptin, ghrelin, irisin, and asprosin) in the same mouse model. These animal studies suggest potential metabolic benefits, though human data remains limited.
Reproductive Health
Research has explored humanin's role in reproductive systems. A 2026 study demonstrated that humanin protected granulosa cells from oxidative stress, while another investigated its potential as a marker of semen quality and freeze tolerance in cattle. These findings suggest protective effects in reproductive tissues, though clinical applications require further study.
Neurological and Eye Conditions
Two studies examined humanin's neuroprotective properties. One investigated its effects against amyloid-beta-induced damage in retinal pigment epithelium cells through a specific cellular pathway (AMPK-Beclin1-dependent mitophagy). Another study tested humanin-G injections for retinal degeneration in rats, showing potential therapeutic effects.
Other Applications
Additional research explored humanin in acute respiratory distress syndrome (ARDS) as a potential therapeutic target, and measured circulating humanin levels in individuals with cerebral palsy during exercise.
Clinical Trials
Three clinical trials are investigating humanin in human patients. One completed study examined humanin levels in cardiac surgery patients, while two ongoing or planned trials are evaluating humanin as a biomarker for acute kidney injury and measuring its levels during different anesthesia approaches in kidney transplant patients. Sample sizes and detailed results from these trials are not yet available.
Current Evidence Limitations
Most research remains in early preclinical stages using animal models. While these studies suggest broad therapeutic potential, human clinical evidence is still emerging, and more robust clinical trials are needed to establish safety and efficacy in humans.
This information is for educational purposes only and should not be considered medical advice. Consult healthcare providers for medical decisions.